Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr;64(4):910-917.
doi: 10.1007/s10620-019-05537-2.

Disease Burden of Hepatocellular Carcinoma: A Global Perspective

Affiliations
Review

Disease Burden of Hepatocellular Carcinoma: A Global Perspective

Mehmet Sayiner et al. Dig Dis Sci. 2019 Apr.

Abstract

Liver cancer is one of the leading causes of cancer-related mortality around the world. Hepatocellular carcinoma (HCC) is the primary cancer of the liver, accounting for the majority of liver cancers. The risk factors associated with HCC include chronic infections with HBV and HCV, alcoholic liver disease, and nonalcoholic fatty liver disease. Additionally, male patients have higher risk for than females, and the risk increases with older age. Mortality rates for HCC parallel its increasing incidence rates. In this context, incidence rate for HCC shows geographic variations in different parts of the world and is heavily affected by regional differences in risk factor for liver disease. The highest incidence rates for HCC are observed in Asia and Africa, while Europe and North America have lower rates. In fact, HBV is still regarded as the leading cause of HCC globally, while HCV is the most common cause of HCC in the USA. Recently, it has been suggested that HCC cases related to nonalcoholic fatty liver disease is on the rise, while the proportion of HCC attributed to alcoholic liver disease remains stable.

Keywords: Epidemiology; Hepatitis B; Hepatitis C; Hepatocellular carcinoma.

PubMed Disclaimer

References

    1. Int J Cancer. 2015 Mar 1;136(5):E359-86 - PubMed
    1. Lancet Gastroenterol Hepatol. 2017 Feb;2(2):103-111 - PubMed
    1. Hepatol Int. 2013 Dec;7 Suppl 2:823-32 - PubMed
    1. Br J Cancer. 2006 Jun 5;94(11):1751-8 - PubMed
    1. J Gastroenterol. 2009;44 Suppl 19:102-7 - PubMed

LinkOut - more resources